vir combination

Generic: influenzinum (2020-2021), herpes simplex 1 nosode, herpes simplex 2 nosode, human herpesvirus 6a, human herpesvirus 6b, cytomegalovirus nosode, hepatitis b nosode, adenoviren nosode, epstein-barr virus nosode

Labeler: deseret biologicals, inc.
NDC Directory HUMAN OTC DRUG UNAPPROVED HOMEOPATHIC Inactive Finished

Drug Facts

Product Profile

Brand Name vir combination
Generic Name influenzinum (2020-2021), herpes simplex 1 nosode, herpes simplex 2 nosode, human herpesvirus 6a, human herpesvirus 6b, cytomegalovirus nosode, hepatitis b nosode, adenoviren nosode, epstein-barr virus nosode
Labeler deseret biologicals, inc.
Dosage Form LIQUID
Routes
ORAL
Active Ingredients

hepatitis b virus 33 [hp_X]/mL, human adenovirus b serotype 7 strain 55142 antigen 12 [hp_X]/mL, human adenovirus e serotype 4 strain cl-68578 antigen 12 [hp_C]/mL, human herpesvirus 1 15 [hp_X]/mL, human herpesvirus 2 15 [hp_X]/mL, human herpesvirus 4 16 [hp_C]/mL, human herpesvirus 5 18 [hp_X]/mL, human herpesvirus 6 15 [hp_X]/mL, influenza a virus a/guangdong-maonan/swl1536/2019 cnic-1909 (h1n1) antigen (formaldehyde inactivated) 12 [hp_X]/mL, influenza a virus a/hong kong/2671/2019 ivr-208 (h3n2) antigen (formaldehyde inactivated) 12 [hp_X]/mL, influenza b virus b/phuket/3073/2013 antigen (formaldehyde inactivated) 12 [hp_X]/mL, influenza b virus b/washington/02/2019 antigen (formaldehyde inactivated) 12 [hp_X]/mL

Manufacturer
Deseret Biologicals, Inc.

Identifiers & Regulatory

Product NDC 43742-2036
Product ID 43742-2036_8df251cd-be49-44d3-b456-badf4ba1c4af
Product Type HUMAN OTC DRUG
Marketing Category UNAPPROVED HOMEOPATHIC
Marketing Start 2021-09-09
Marketing End 2026-10-01

Pharmacologic Class

Classes
actively acquired immunity [pe] live human adenovirus type 4 vaccine [epc] live human adenovirus type 7 vaccine [epc] vaccines adenovirus [chemical/ingredient] live unattenuated [chemical/ingredient]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 437422036
Hyphenated Format 43742-2036

Supplemental Identifiers

UNII
77H9EM77P7 TM54L796SN FKD3DUK39I 22G38P19RL 74J6DNH49U 2A26YW7PNX 7COI029E6K 4IX4VP35CR NY1FF92M1E P8ORN3UOM6 B93BQX9789 VEH9U90EHX

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name vir combination (source: ndc)
Generic Name influenzinum (2020-2021), herpes simplex 1 nosode, herpes simplex 2 nosode, human herpesvirus 6a, human herpesvirus 6b, cytomegalovirus nosode, hepatitis b nosode, adenoviren nosode, epstein-barr virus nosode (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 33 [hp_X]/mL
  • 12 [hp_X]/mL
  • 12 [hp_C]/mL
  • 15 [hp_X]/mL
  • 16 [hp_C]/mL
  • 18 [hp_X]/mL
source: ndc
Packaging
  • 30 mL in 1 BOTTLE, DROPPER (43742-2036-1)
source: ndc

Packages (1)

43742-2036-1 30 mL in 1 BOTTLE, DROPPER (43742-2036-1)

Ingredients (12)

hepatitis b virus (33 [hp_X]/mL) human adenovirus b serotype 7 strain 55142 antigen (12 [hp_X]/mL) human adenovirus e serotype 4 strain cl-68578 antigen (12 [hp_C]/mL) human herpesvirus 1 (15 [hp_X]/mL) human herpesvirus 2 (15 [hp_X]/mL) human herpesvirus 4 (16 [hp_C]/mL) human herpesvirus 5 (18 [hp_X]/mL) human herpesvirus 6 (15 [hp_X]/mL) influenza a virus a/guangdong-maonan/swl1536/2019 cnic-1909 (h1n1) antigen (formaldehyde inactivated) (12 [hp_X]/mL) influenza a virus a/hong kong/2671/2019 ivr-208 (h3n2) antigen (formaldehyde inactivated) (12 [hp_X]/mL) influenza b virus b/phuket/3073/2013 antigen (formaldehyde inactivated) (12 [hp_X]/mL) influenza b virus b/washington/02/2019 antigen (formaldehyde inactivated) (12 [hp_X]/mL)

Linked Drug Pages (1)

Vir Combination ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "8df251cd-be49-44d3-b456-badf4ba1c4af", "openfda": {"unii": ["77H9EM77P7", "TM54L796SN", "FKD3DUK39I", "22G38P19RL", "74J6DNH49U", "2A26YW7PNX", "7COI029E6K", "4IX4VP35CR", "NY1FF92M1E", "P8ORN3UOM6", "B93BQX9789", "VEH9U90EHX"], "spl_set_id": ["d48d741e-c6b2-45bd-a102-9b793f62a53c"], "manufacturer_name": ["Deseret Biologicals, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 mL in 1 BOTTLE, DROPPER (43742-2036-1)", "package_ndc": "43742-2036-1", "marketing_end_date": "20261001", "marketing_start_date": "20210909"}], "brand_name": "Vir Combination", "product_id": "43742-2036_8df251cd-be49-44d3-b456-badf4ba1c4af", "dosage_form": "LIQUID", "pharm_class": ["Actively Acquired Immunity [PE]", "Actively Acquired Immunity [PE]", "Live Human Adenovirus Type 4 Vaccine [EPC]", "Live Human Adenovirus Type 7 Vaccine [EPC]", "Vaccines", "Adenovirus [Chemical/Ingredient]", "Vaccines", "Adenovirus [Chemical/Ingredient]", "Vaccines", "Live", "Unattenuated [Chemical/Ingredient]", "Vaccines", "Live", "Unattenuated [Chemical/Ingredient]"], "product_ndc": "43742-2036", "generic_name": "Influenzinum (2020-2021), Herpes Simplex 1 Nosode, Herpes Simplex 2 Nosode, Human Herpesvirus 6A, Human Herpesvirus 6B, Cytomegalovirus Nosode, Hepatitis B Nosode, Adenoviren Nosode, Epstein-Barr Virus Nosode", "labeler_name": "Deseret Biologicals, Inc.", "product_type": "HUMAN OTC DRUG", "brand_name_base": "Vir Combination", "active_ingredients": [{"name": "HEPATITIS B VIRUS", "strength": "33 [hp_X]/mL"}, {"name": "HUMAN ADENOVIRUS B SEROTYPE 7 STRAIN 55142 ANTIGEN", "strength": "12 [hp_X]/mL"}, {"name": "HUMAN ADENOVIRUS E SEROTYPE 4 STRAIN CL-68578 ANTIGEN", "strength": "12 [hp_C]/mL"}, {"name": "HUMAN HERPESVIRUS 1", "strength": "15 [hp_X]/mL"}, {"name": "HUMAN HERPESVIRUS 2", "strength": "15 [hp_X]/mL"}, {"name": "HUMAN HERPESVIRUS 4", "strength": "16 [hp_C]/mL"}, {"name": "HUMAN HERPESVIRUS 5", "strength": "18 [hp_X]/mL"}, {"name": "HUMAN HERPESVIRUS 6", "strength": "15 [hp_X]/mL"}, {"name": "INFLUENZA A VIRUS A/GUANGDONG-MAONAN/SWL1536/2019 CNIC-1909 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED)", "strength": "12 [hp_X]/mL"}, {"name": "INFLUENZA A VIRUS A/HONG KONG/2671/2019 IVR-208 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED)", "strength": "12 [hp_X]/mL"}, {"name": "INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED)", "strength": "12 [hp_X]/mL"}, {"name": "INFLUENZA B VIRUS B/WASHINGTON/02/2019 ANTIGEN (FORMALDEHYDE INACTIVATED)", "strength": "12 [hp_X]/mL"}], "marketing_category": "UNAPPROVED HOMEOPATHIC", "marketing_end_date": "20261001", "marketing_start_date": "20210909"}